Bhopal: AIIMS Bhopal is stepping into the future of healthcare with a new partnership with Erasmus Medical Center, Rotterdam, The Netherlands. Together, they will work on cutting-edge research in pharmacogenomics — the science of how our genes affect the way medicines work.For patients, the collaboration promises more personalised treatment. Instead of relying on the same medicine for everyone, genetic testing could help doctors identify which drug will work best for each individual, leading to safer prescriptions, fewer side effects and faster recovery.This research aims to evaluate scalability, clinical utility, and health-economic impact, with the goal of making treatments more personalized and cost-effective.A high-level delegation from Erasmus Medical Centre, led by Prof Peter J van der Spek, head of clinical bioinformatics, visited AIIMS Bhopal and met with the institute director Dr Madhabananda Kar. During the meeting, a letter of intent was presented to strengthen academic cooperation between the two institutions. The proposed project, valued at over Rs 10 crores, will be spearheaded by Dr Shubham Atal, additional professor in the Department of Pharmacology at AIIMS Bhopal, who will serve as the principal investigator. Prof (Dr) Madhabananda Kar welcomed the initiative, while Prof. Peter J. van der Spek highlighted the potential to build a robust Indo–Dutch partnership in precision medicine.End of ArticleFollow Us On Social MediaVideosPakistan To Repay $4.8 Billion In External Debt By June, Including $3.5 Billion To UAE: ReportJaishankar Speaks To Qatar PM, India Ramps Up Diplomatic Outreach Amid Iran EscalationUAPA Terror Case: NIA Court Sends US Citizen, 6 Ukrainians To 30-Day Judicial Custody‘Jointness To Theatre Commands Is Not Simple’: Lt Gen PJS Pannu On India’s Military ReformsModi Vs Mamata, Himanta Vs Gogoi: Why Pakistan Features In Bengal, Assam Poll RhetoricKhalistan Call In Canada Falls Flat, Low Turnout Exposes Gap Between Online Noise And Ground Reality’Left-Wing Extremism Not Over Yet’: Anand Ranganathan Warns as Amit Shah Calls India Naxal-Free’War Not A Roadblock’: Iran Envoy Fathali Says Chabahar Port Expansion Will Speed Up Post ConflictMajor Security Breach At Delhi Assembly As Car Rams Gate, Driver And Two Others ArrestedPM Modi Hails BJP Karyakartas for Selfless Service on Party’s Foundation Day123PhotostoriesHow to make Pizza in an air fryer in just 8 minutes for midnight munchingArti Singh on losing her mother as an infant, opens up about motherhood plans; says, “If I don’t conceive naturally, I’ll adopt—I’m an adopted child myself”10 rare and extraordinary animals you will only find in KenyaBTS concert moments that broke the internet: From Wembley to the Love Yourself tour10 simple ways to respect yourself (Even when no one else does)5 easy meal preps for Indian kitchens to save time during busy weekdaysDifference between Circle Rate and Market Rate in India: What every property buyer must know‘City of God’ to ‘Neelakasham Pachakadal Chuvanna Bhoomi’: Malayalam underrated masterpieces‘Bloodhounds 2’, ‘Perfect Crown’ to ‘The Scarecrow’: K-dramas releasing in April 2026 you can stream on OTT‘Maamla Legal Hai’, ‘Trial By Fire’ to ‘Criminal Justice’: Binge-worthy courtroom dramas to watch on OTT123Hot PicksDonald TrumpUpdated IPL Points TableStephen Curry MomSilver Rate TodayIran war newsPublic holidays April 2026Bank Holidays AprilTop TrendingRory McilroyKevin PietersenTaylor Swift WeedingDak PrescottLindsey GrahamGigi HadidAngel ReeseIPL Points TableSchool Holidays in AprilKarnataka 2nd PUC Exam Result Date
Bhopal: AIIMS Bhopal is stepping into the future of healthcare with a new partnership with Erasmus Medical Center, Rotterdam, The Netherlands. Together, they will work on cutting-edge research in pharmacogenomics — the science of how our genes affect the way medicines work.For patients, the collaboration promises more personalised treatment. Instead of relying on the same medicine for everyone, genetic testing could help doctors identify which drug will work best for each individual, leading to safer prescriptions, fewer side effects and faster recovery.This research aims to evaluate scalability, clinical utility, and health-economic impact, with the goal of making treatments more personalized and cost-effective.A high-level delegation from Erasmus Medical Centre, led by Prof Peter J van der Spek, head of clinical bioinformatics, visited AIIMS Bhopal and met with the institute director Dr Madhabananda Kar. During the meeting, a letter of intent was presented to strengthen academic cooperation between the two institutions. The proposed project, valued at over Rs 10 crores, will be spearheaded by Dr Shubham Atal, additional professor in the Department of Pharmacology at AIIMS Bhopal, who will serve as the principal investigator. Prof (Dr) Madhabananda Kar welcomed the initiative, while Prof. Peter J. van der Spek highlighted the potential to build a robust Indo–Dutch partnership in precision medicine.
